In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions

Recruiting N/A Interventional Study
Fetal Alcohol Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Diagnostic
Participants needed
60 (estimated)
Sponsor
University Hospital, Rouen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Mother: * Pregnant woman (monofetal or twin pregnancy, whatever the parity) * Age\> or = to 18 years * Person affiliated to a social security system * Person who read and understood the information form and signed the consent form * Alcohol exposure group Chronic consumption…
Contacts

POURCHER

02 32 88 82 65

cecile.pourcher@chu-rouen.fr

CONTACT

BLOT

02 32 88 82 65

julien.blot@chu-rouen.fr

CONTACT